(Post-pandemic Era)-Global The Human VEGF Antibody Market Segment Research Report 2024

Report ID: 875255 | Published Date: Jan 2026 | No. of Page: 112 | Base Year: 2025 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

Table of Contents

Global The Human VEGF Antibody Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Human VEGF Antibody Market by Value
      2.2.1 Global The Human VEGF Antibody Revenue by Type
      2.2.2 Global The Human VEGF Antibody Market by Value (%)
    2.3 Global The Human VEGF Antibody Market by Production
      2.3.1 Global The Human VEGF Antibody Production by Type
      2.3.2 Global The Human VEGF Antibody Market by Production (%)

3. The Major Driver of The Human VEGF Antibody Industry
    3.1 Historical & Forecast Global The Human VEGF Antibody Demand
    3.2 Largest Application for The Human VEGF Antibody (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Human VEGF Antibody Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Human VEGF Antibody Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Human VEGF Antibody Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Human VEGF Antibody Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Human VEGF Antibody Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Human VEGF Antibody Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Human VEGF Antibody Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Human VEGF Antibody Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Human VEGF Antibody Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Human VEGF Antibody Average Price Trend
    12.1 Market Price for Each Type of The Human VEGF Antibody in US (2017-2021)
    12.2 Market Price for Each Type of The Human VEGF Antibody in Europe (2017-2021)
    12.3 Market Price for Each Type of The Human VEGF Antibody in China (2017-2021)
    12.4 Market Price for Each Type of The Human VEGF Antibody in Japan (2017-2021)
    12.5 Market Price for Each Type of The Human VEGF Antibody in India (2017-2021)
    12.6 Market Price for Each Type of The Human VEGF Antibody in Korea (2017-2021)
    12.7 Market Price for Each Type of The Human VEGF Antibody in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Human VEGF Antibody Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Human VEGF Antibody

14. The Human VEGF Antibody Competitive Landscape
     14.1 Thermo Fisher
        14.1.1 Thermo Fisher Company Profiles
        14.1.2 Thermo Fisher Product Introduction
        14.1.3 Thermo Fisher The Human VEGF Antibody Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 ImmunoStar
        14.2.1 ImmunoStar Company Profiles
        14.2.2 ImmunoStar Product Introduction
        14.2.3 ImmunoStar The Human VEGF Antibody Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Abcam
        14.3.1 Abcam Company Profiles
        14.3.2 Abcam Product Introduction
        14.3.3 Abcam The Human VEGF Antibody Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 MilliporeSigma
        14.4.1 MilliporeSigma Company Profiles
        14.4.2 MilliporeSigma Product Introduction
        14.4.3 MilliporeSigma The Human VEGF Antibody Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Abnova
        14.5.1 Abnova Company Profiles
        14.5.2 Abnova Product Introduction
        14.5.3 Abnova The Human VEGF Antibody Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 Santa Cruz Biotechnology
        14.6.1 Santa Cruz Biotechnology Company Profiles
        14.6.2 Santa Cruz Biotechnology Product Introduction
        14.6.3 Santa Cruz Biotechnology The Human VEGF Antibody Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 LifeSpan Biosciences
        14.7.1 LifeSpan Biosciences Company Profiles
        14.7.2 LifeSpan Biosciences Product Introduction
        14.7.3 LifeSpan Biosciences The Human VEGF Antibody Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 Novus Biologicals
        14.8.1 Novus Biologicals Company Profiles
        14.8.2 Novus Biologicals Product Introduction
        14.8.3 Novus Biologicals The Human VEGF Antibody Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 R&D Systems
        14.9.1 R&D Systems Company Profiles
        14.9.2 R&D Systems Product Introduction
        14.9.3 R&D Systems The Human VEGF Antibody Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 OriGene
        14.10.1 OriGene Company Profiles
        14.10.2 OriGene Product Introduction
        14.10.3 OriGene The Human VEGF Antibody Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
     14.11 Agrisera
     14.12 Creative Biomart
     14.13 Sino Biological
     14.14 Bon Opus Biosciences
     14.15 Boster
     14.16 Rockland Immunochemicals
     14.17 Bio-Rad
     14.18 Enzo Life Sciences
     14.19 ProMab
     14.20 BioLegend
     14.21 Absolute Antibody
     14.22 US Biological
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Human VEGF Antibody Industry (Volume)
    Figure 2. The Human VEGF Antibody Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Human VEGF Antibody Revenue in 2021
    Figure 5. US The Human VEGF Antibody Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Human VEGF Antibody Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Human VEGF Antibody Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Human VEGF Antibody Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Human VEGF Antibody Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Human VEGF Antibody Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Human VEGF Antibody Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Human VEGF Antibody Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Human VEGF Antibody Production, by Type (K Unit) (2017-2027)
    Table 5. The Human VEGF Antibody Demand (K Unit) by Application (2017-2027)
    Table 6. The Human VEGF Antibody Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Human VEGF Antibody Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Human VEGF Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Human VEGF Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Human VEGF Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Human VEGF Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Human VEGF Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Human VEGF Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Human VEGF Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Human VEGF Antibody in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Human VEGF Antibody in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Human VEGF Antibody in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Human VEGF Antibody in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Human VEGF Antibody in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Human VEGF Antibody in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Human VEGF Antibody in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. Thermo Fisher Profiles
    Table 61. Thermo Fisher The Human VEGF Antibody Product Introduction
    Table 62. Thermo Fisher The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. Thermo Fisher Strategic initiatives
    Table 64. ImmunoStar Profiles
    Table 65. ImmunoStar The Human VEGF Antibody Product Introduction
    Table 66. ImmunoStar The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. ImmunoStar Strategic initiatives
    Table 68. Abcam Profiles
    Table 69. Abcam The Human VEGF Antibody Product Introduction
    Table 70. Abcam The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Abcam Strategic initiatives
    Table 72. MilliporeSigma Profiles
    Table 73. MilliporeSigma The Human VEGF Antibody Product Introduction
    Table 74. MilliporeSigma The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. MilliporeSigma Strategic initiatives
    Table 76. Abnova Profiles
    Table 77. Abnova The Human VEGF Antibody Product Introduction
    Table 78. Abnova The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. Abnova Strategic initiatives
    Table 80. Santa Cruz Biotechnology Profiles
    Table 81. Santa Cruz Biotechnology The Human VEGF Antibody Product Introduction
    Table 82. Santa Cruz Biotechnology The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. Santa Cruz Biotechnology Strategic initiatives
    Table 84. LifeSpan Biosciences Profiles
    Table 85. LifeSpan Biosciences The Human VEGF Antibody Product Introduction
    Table 86. LifeSpan Biosciences The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. LifeSpan Biosciences Strategic initiatives
    Table 88. Novus Biologicals Profiles
    Table 89. Novus Biologicals The Human VEGF Antibody Product Introduction
    Table 90. Novus Biologicals The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. Novus Biologicals Strategic initiatives
    Table 92. R&D Systems Profiles
    Table 93. R&D Systems The Human VEGF Antibody Product Introduction
    Table 94. R&D Systems The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. R&D Systems Strategic initiatives
    Table 97. OriGene Profiles
    Table 98. OriGene The Human VEGF Antibody Product Introduction
    Table 99. OriGene The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 100. OriGene Strategic initiatives
    Table 101. Agrisera Profiles
    Table 102. Agrisera The Human VEGF Antibody Product Introduction
    Table 103. Agrisera The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 104. Agrisera Strategic initiatives
    Table 105. Creative Biomart Profiles
    Table 106. Creative Biomart The Human VEGF Antibody Product Introduction
    Table 107. Creative Biomart The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 108. Creative Biomart Strategic initiatives
    Table 109. Sino Biological Profiles
    Table 110. Sino Biological The Human VEGF Antibody Product Introduction
    Table 111. Sino Biological The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 112. Sino Biological Strategic initiatives
    Table 113. Bon Opus Biosciences Profiles
    Table 114. Bon Opus Biosciences The Human VEGF Antibody Product Introduction
    Table 115. Bon Opus Biosciences The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 116. Bon Opus Biosciences Strategic initiatives
    Table 117. Boster Profiles
    Table 118. Boster The Human VEGF Antibody Product Introduction
    Table 119. Boster The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 120. Boster Strategic initiatives
    Table 121. Rockland Immunochemicals Profiles
    Table 122. Rockland Immunochemicals The Human VEGF Antibody Product Introduction
    Table 123. Rockland Immunochemicals The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 124. Rockland Immunochemicals Strategic initiatives
    Table 125. Bio-Rad Profiles
    Table 126. Bio-Rad The Human VEGF Antibody Product Introduction
    Table 127. Bio-Rad The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 128. Bio-Rad Strategic initiatives
    Table 129. Enzo Life Sciences Profiles
    Table 130. Enzo Life Sciences The Human VEGF Antibody Product Introduction
    Table 131. Enzo Life Sciences The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 132. Enzo Life Sciences Strategic initiatives
    Table 133. ProMab Profiles
    Table 134. ProMab The Human VEGF Antibody Product Introduction
    Table 135. ProMab The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 136. ProMab Strategic initiatives
    Table 137. BioLegend Profiles
    Table 138. BioLegend The Human VEGF Antibody Product Introduction
    Table 139. BioLegend The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 140. BioLegend Strategic initiatives
    Table 141. Absolute Antibody Profiles
    Table 142. Absolute Antibody The Human VEGF Antibody Product Introduction
    Table 143. Absolute Antibody The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 144. Absolute Antibody Strategic initiatives
    Table 145. US Biological Profiles
    Table 146. US Biological The Human VEGF Antibody Product Introduction
    Table 147. US Biological The Human VEGF Antibody Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Human VEGF Antibody Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Human VEGF Antibody Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Human VEGF Antibody Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports